Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abtard 20mg modified-release tablets
0407020ADBMADAG
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 3 |
|
Alprazolam 250microgram tablets
0401020A0AAAAAA
|
Alprazolam | Alprazolam | Central Nervous System | 3 |
|
Anquil 250microgram tablets
0402010B0BBAAAA
|
Anquil | Benperidol | Central Nervous System | 3 |
|
APO-go 50mg/5ml solution for injection ampoules
0409010A0BCAAAV
|
APO-go | Apomorphine hydrochloride | Central Nervous System | 3 |
|
Aprepitant 125mg capsules
0406000ADAAABAB
|
Aprepitant | Aprepitant | Central Nervous System | 3 |
|
Aripiprazole 9.75mg/1.3ml solution for injection vials
0402010ADAAAHAH
|
Aripiprazole | Aripiprazole | Central Nervous System | 3 |
|
Aspirin 150mg suppositories
0407010B0AABCBC
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 3 |
|
Beacita 120mg capsules
0405010P0BDAAAA
|
Beacita | Orlistat | Central Nervous System | 3 |
|
Botox 100unit powder for solution for injection vials
0409030B0BCAAAE
|
Botox | Botulinum toxin type A | Central Nervous System | 3 |
|
Buplast 35micrograms/hour transdermal patches
0407020B0BNAAAE
|
Buplast | Buprenorphine | Central Nervous System | 3 |
|
Buprenorphine 32mg/0.64ml prolonged-release inj pfs
0410030A0AAARAR
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 3 |
|
Buspirone 5mg/5ml oral suspension
0401020B0AAAGAG
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 3 |
|
Caffeine citrate 50mg/5ml oral solution
0404000E0AAAKAK
|
Caffeine citrate | Caffeine citrate | Central Nervous System | 3 |
|
Chloral hydrate 200mg/5ml oral solution sugar free
0401010B0AABYBY
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 3 |
|
Citalopram 20mg/5ml oral suspension
0403030D0AAADAD
|
Citalopram hydrobromide | Citalopram hydrobromide | Central Nervous System | 3 |
|
Consion XL 8mg capsules
0411000F0BLAAAE
|
Consion XL | Galantamine | Central Nervous System | 3 |
|
Cynril 1.6mg lozenges with integral oromucosal applicator
0407020A0BWAFAP
|
Cynril | Fentanyl | Central Nervous System | 3 |
|
Denzapine 50mg tablets
0402010C0BCACAC
|
Denzapine | Clozapine | Central Nervous System | 3 |
|
Domperidone 50mg/5ml oral suspension
0406000J0AAAFAF
|
Domperidone | Domperidone | Central Nervous System | 3 |
|
Enodama 250mg tablets
0408010U0BCACAB
|
Enodama | Primidone | Central Nervous System | 3 |
|
Epilim Intravenous 400mg inj vials
0408010W0BBAIAH
|
Epilim | Sodium valproate | Central Nervous System | 3 |
|
Eplaid 100mg tablets
0408010AHBCABAB
|
Eplaid | Lacosamide | Central Nervous System | 3 |
|
Eplaid 200mg tablets
0408010AHBCADAD
|
Eplaid | Lacosamide | Central Nervous System | 3 |
|
Eplaid 50mg tablets
0408010AHBCAAAA
|
Eplaid | Lacosamide | Central Nervous System | 3 |
|
Felbamate 600mg/5ml oral suspension
0408010AAAAACAC
|
Felbamate | Felbamate | Central Nervous System | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.